Skip to content
healthcare.dev
Get a free key

Acamprosate Calcium

NDC 68462-435, Acamprosate Calcium, tablet, delayed release, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-435
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202229
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-435 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACAMPROSATE CALCIUM333 mg/1
Package NDCNDC-11Package
68462-435-116846204351110 BLISTER PACK in 1 CARTON (68462-435-11) / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK
68462-435-1868462043518180 TABLET, DELAYED RELEASE in 1 BOTTLE (68462-435-18)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/43e9ef60-2d85-4394-906b-93042fea099a

  • NADAC price for package 68462043518

    GET /v1/drugs/nadac/68462043518

Use it

Look up 68462-435 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-435 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-435. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.